The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,050.00
Bid: 12,038.00
Ask: 12,040.00
Change: -106.00 (-0.87%)
Spread: 2.00 (0.017%)
Open: 12,092.00
High: 12,178.00
Low: 12,010.00
Prev. Close: 12,156.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

India's COVID-19 cases multiply, vulnerable groups given vaccine boosters

Mon, 10th Jan 2022 04:39

NEW DELHI, Jan 10 (Reuters) - India began administering
booster doses of COVID-19 vaccine to frontline workers and
vulnerable elderly people on Monday, with the fast-spreading
Omicron variant fuelling an almost eight-fold rise in daily
infections since the start of the year.

India reported 179,723 new cases on Monday, most of them in
the country's biggest cities - Delhi, Mumbai and Kolkata - where
Omicron has overtaken Delta as the most prevalent strain of the
virus.

There were 146 deaths reported on Monday, bringing the toll
to 483,936 since the pandemic first struck India in early 2020.
Only the United States and Brazil have recorded more deaths.

In recent days, hundreds of healthcare and frontline
workers, including police, have contracted the virus, and there
were media reports that hundreds of parliamentary staff have
also tested positive ahead of a budget session on Feb. 1.

Facing this rising third wave of infections, the government
sent booster reminders to more than 10 million people who took
their second dose of the Covaxin or Covishield shot nine months
ago.

Unlike many countries, India is not mixing and matching
vaccines.

Only healthcare personnel, frontline workers and people
above 60 years suffering from other health conditions are
eligible for what the government calls a "precaution dose".

"The government is committed to provide additional security
cover to healthcare and frontline workers on priority," Health
Minister Mansukh Mandaviya wrote on Twitter.

Despite the rise in infections, five states including the
most populous Uttar Pradesh will hold elections starting Feb.
10, though authorities have barred political party rallies until
at least the middle of this month.

Tasked with protecting India's near 1.4 billion people from
the virus, the government has administered 1.5 billion vaccine
doses in total. About 67% of the country's 939 million adults
have been double vaccinated.

India's overall COVID-19 testing has remained around 1.5
million a day, well below the capacity of more than 2 million.

Since the pandemic began, India has recorded 35.7 million
cases of COVID-19, the highest in the world after the United
States.

Government officials have privately said they are working
under the assumption that daily infections will surpass the
record of more than 414,000 set in May, based on what has
happened in countries like the United States, where daily cases
have risen past 1 million.
(Reporting by Krishna N. Das in New Delhi, Chandini Monnappa in
Bengaluru and Subrata Nagchoudhury in Kolkata; Editing by Simon
Cameron-Moore)

More News
3 May 2024 12:17

CORRECT: Angle shares up on assay development deal with AstraZeneca

(Correcting company name in headline)

Read more
3 May 2024 11:50

Angle shares up on assay development deal with AstraZenaca

(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsortix technology, opening the door for future clinical study-supporting contracts.

Read more
3 May 2024 07:50

LONDON BRIEFING: InterContinental Hotels makes first-quarter progress

(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out of hawkish Federal Reserve interest rate expectations.

Read more
2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for previously untreated adult patients with mantle cell lymphoma.

Read more
2 May 2024 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood cancer.

Read more
29 Apr 2024 22:52

J&J, Bristol Myers lose challenges to US drug price negotiation program

April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negotiate the prices of their blockbuster blood clot prevention drugs with the U.S government's Medicare health insurance program or pay heavy penalties.

Read more
29 Apr 2024 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
29 Apr 2024 09:13

AstraZeneca makes progress with Truqap and Enhertu cancer treatments

(Alliance News) - AstraZeneca PLC on Monday said its Truqap drug has been recommended for approval in the EU to treat a form of breast cancer, while also noting trial results for its Enhertu offering.

Read more
29 Apr 2024 07:50

LONDON BRIEFING: Hipgnosis Songs Fund backs new Blackstone bid

(Alliance News) - London's FTSE 100 is called to open higher on Monday, with heady gains for US tech stocks on Friday brightening the mood in Europe and Asia at the start of the new week.

Read more
29 Apr 2024 07:24

AstraZeneca makes progress with two breast cancer treatments

(Sharecast News) - AstraZeneca issued favourable updates on two of its breast cancer treatments on Monday - 'Truqap', or capivasertib, and 'Enhertu', or trastuzumab deruxtecan - following encouraging results from respective phase three trials.

Read more
26 Apr 2024 09:33

LONDON BROKER RATINGS: Peel Hunt cuts ConvaTec to 'reduce'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
25 Apr 2024 16:57

LONDON MARKET CLOSE: FTSE 100 shakes off red-hot US inflation gauge

(Alliance News) - London's FTSE 100 outperformed on Thursday, enjoying a solid rise on largely well-received corporate earnings and a share price jump for miner Anglo American after it received a takeover bid from peer BHP.

Read more
25 Apr 2024 15:14

London close: Stocks finish mixed as US GDP growth slows

(Sharecast News) - London's stock markets finished with a mixed performance on Thursday, as investors digested a slower-than-expected GDP growth reading from the United States, while a slew of well-received earnings underpinned the top-flight index.

Read more
25 Apr 2024 11:50

LONDON MARKET MIDDAY: FTSE 100 hits high on offer for Anglo American

(Alliance News) - The FTSE 100 was outperforming European markets at midday on Thursday, with the index boosted to a record high thanks to takeover talks.

Read more
25 Apr 2024 10:33

AstraZeneca leaps after smashing first-quarter forecasts

Q1 revenue up 19% to $12.68 bln

*

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.